Home
About
Overview
Sharing Data
ORCID
Help
History (35)
Mark A. Smith: neurocytochemistry innovator.
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.
Miles, Randy
Co-Principal Investigator
Co-Principal Investigator
See All 35 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Co-Principal Investigator
Overview
contributes to
Genetics and Regulation
